We are pleased to announce that Scantox will be exhibiting at AD/PD™ 2027, taking place in March 2027 in Barcelona, Spain.
Recognized as one of the leading global conferences in neurodegenerative disease research, AD/PD™ brings together renowned scientists, clinicians, and industry experts dedicated to advancing the understanding, prevention, and treatment of Alzheimer’s disease, Parkinson’s disease, and related disorders.
As a leading CRO in neuropharmacology, Scantox offers a comprehensive portfolio of validated in vivo and in vitro models, including both transgenic and non-transgenic solutions designed to support preclinical neurodegeneration research. The conference provides an excellent opportunity to learn more about our capabilities and discover how our expertise can help drive your next research project forward.
Visit us at Booth 34, or connect with our scientists during our poster presentations to discuss your upcoming studies and explore how Scantox can help accelerate your research.
We look forward to meeting you in Barcelona.
